NCT02301585

Brief Summary

A randomized controlled clinical trial to evaluate whether a passive leg raising test to guide fluid therapy of patients with septic shock can reduce fluid balance and weight gain. Patients will be treated according to an algorithm in which the indexed stroke volume (stroke volume related to body surface area) and mean arterial pressure will guide the timing and amount of fluid and the use of inotropic and vasoactive support. Patients will be randomized to either an intervention group in which a passive leg raising test will be made prior to any decision for fluid administration or to a control group where this test is not performed and fluid administration is carried out according to standard of care at the department. Hypothesis: A passive leg raising test, will reduce weight gain by day 3 by 30%.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2014

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

September 14, 2014

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 26, 2014

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2016

Completed
Last Updated

February 9, 2016

Status Verified

February 1, 2016

Enrollment Period

2 years

First QC Date

September 14, 2014

Last Update Submit

February 8, 2016

Conditions

Keywords

shock, septichemodynamicsalgorithms

Outcome Measures

Primary Outcomes (1)

  • weight gain

    3 days

Secondary Outcomes (5)

  • ICU length of stay

    measured within 90 days after inclusion

  • Cumulative fluid balance study day 1,2,3

    Study day 1,2,3

  • 30 day mortality

    30 days from inclusion in the study

  • Organ support during ICU stay

    ICU-stay

  • ICU discharge status

    End of ICU stay

Study Arms (2)

Passive Leg Raising

EXPERIMENTAL

Before decision on fluid administration a passive leg raising test is performed. If the test indicates fluid irresponsiveness optimization of circulation will be done with vasopressors or inotropes.

Procedure: Passive Leg Raising Test

Standard of care

ACTIVE COMPARATOR

Patients are treated according to Surviving Sepsis Guidelines. Fluid is administered according to the choice of the clinician.

Procedure: Standard of care

Interventions

Before decision on fluid administration a passive leg raising test is performed. The results are interpreted according to a treatment protocol. If the test indicates fluid irresponsiveness optimization of circulation will be done with vasopressors or inotropes.

Passive Leg Raising

Patients are treated according to Surviving Sepsis Guidelines

Standard of care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients \>18 years admitted to the ICU diagnosed with circulatory shock due to suspected sepsis or pancreatitis. Circulatory shock is defined as MAP\<70 mm Hg or need for norepinephrine despite resuscitation with ≥30 ml/kg of crystalloid fluids.

You may not qualify if:

  • \> 12 hours have passed after onset of shock. The patient has contraindications for an arterial femoral/axillary line. Elevated ICP. Patients who have had a femoral amputation. Elevated intraabdominal pressure\>20 cm H2O.
  • Suspension criteria: The patient has developed pulmonary oedema during PLR test. Life threatening bleeding.
  • Serious adverse events:
  • Trombosis in arteria femoralis. Death during the study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska Institutet Södersjukhuset

Stockholm, 11883, Sweden

Location

MeSH Terms

Conditions

Shock, Septic

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

SepsisInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Christer Svensen, Prof

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 14, 2014

First Posted

November 26, 2014

Study Start

February 1, 2014

Primary Completion

February 1, 2016

Study Completion

February 1, 2016

Last Updated

February 9, 2016

Record last verified: 2016-02

Locations